Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells

Oncology Reports

Volumn 21, Issue 2, 2009, Pages 305-312

  Dobashi, Sachiko ^a   Katagiri, Toyomasa ^a,e   Hirota, Eiji ^a,b   Ashida, Singo ^c   Daigo, Yataro ^a   Shuin, Taro ^c   Fujioka, Tomoaki ^d   Miki, Tsuneharu ^b   Nakamura, Yusuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

cDNA microarray; Membrane protein; Molecular target

Indexed keywords

MEMBRANE PROTEIN; PROTEIN RAB37; PROTEIN TMEM22; RAS PROTEIN; SMALL INTERFERING RNA; TRANSMEMBRANE PROTEIN 22; UNCLASSIFIED DRUG; RAB PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL MEMBRANE; COMPLEX FORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KIDNEY CARCINOMA; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CELL PROLIFERATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KIDNEY TUMOR; METABOLISM; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KIDNEY NEOPLASMS; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RAB GTP-BINDING PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 62849091590     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000222     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global Cancer Statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Cohen HT and McGovern FJ: Renal-cell carcinoma. N Engl J Med 353: 2477-2490, 2005.
3. Lane BR, Rini BI, Novick AC and Campbell SC: Targeted molecular therapy for renal cell carcinoma. Urology 69: 3-10, 2007.
4. Costa LJ and Drabkin HA: Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies. Oncologist 12: 1404-1415, 2007.
5. Rini BI, Rathmell WK and Godley P: Renal cell carcinoma. Curr Opin Oncol 20: 300-306, 2008.
6. Petricoin EF 3rd, Hackett JL, Lesko LJ, Puri RK, Gutman SI, Chumakov K, Woodcock J, Feigal DW Jr, Zoon KC and Sistare FD: Medical applications of microarray technologies: a regulatory science perspective. Nat Genet 32: 474-479, 2002.
7. Togashi A, Katagiri T, Ashida S, Fujioka T, Maruyama O, Wakumoto Y, Sakamoto Y, Fujime M, Kawachi Y, Shuin T and Nakamura Y: Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res 65: 4817-4826, 2005.
8. Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y and Katagiri T: Genome-wide gene expression profiles of clear cell renal cell carcinoma: Identification of molecular targets for treatment of renal cell carcinoma. Int J Oncol 29: 799-827, 2006.
9. Kanehira M, Katagiri T, Shimo A, Takata R, Shuin T, Miki T, Fujioka T and Nakamura Y: Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer. Cancer Res 67: 3276-3285, 2007.
10. Kanehira M, Harada Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y and Katagiri T: Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene 26: 6448-6455, 2007.
11. Park JH, Lin ML, Nishidate T, Nakamura Y and Katagiri T: PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res 66: 9186-9195, 2006.
12. Shimo A, Nishidate T, Ohta T, Fukuda M, Nakamura Y and Katagiri T: Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells. Cancer Sci 98: 174-181, 2007.
13. Lin ML, Park JH, Nishidate T, Nakamura Y and Katagiri T: Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of Bcl-2 family. Breast Cancer Res 9: R17, 2007.
14. Shimo A, Tanikawa C, Nishidate T, Lin ML, Matsuda K, Park JH, Ueki T, Ohta T, Hirata K, Fukuda M, Nakamura Y and Katagiri T: Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer Sci 99: 62-70, 2008.
15. Ueki T, Nishidate T, Park JH, Lin ML, Shimo A, Hirata K, Nakamura Y and Katagiri T: Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells. Oncogene (In press).
16. Rozsa FW, Scott KM, Pawar H, Samples JR, Wirtz MK and Richards JE: Differential expression profile prioritization of positional candidate glaucoma genes: the GLC1C locus. Arch Ophthalmol 125: 117-127, 2007.
17. Katagiri T, Ozaki K, Fujiwara T, Shimizu F, Kawai A, Okuno S, Suzuki M, Nakamura Y, Takahashi E and Hirai Y: Cloning, expression and chromosome mapping of adducin-like 70 (ADDL), a human cDNA highly homologous to human erythrocyte adducin. Cytogenet Cell Genet 74: 90-95, 1996.
18. Masuda ES, Luo Y, Young C, Shen M, Rossi AB, Huang BC, Yu S, Bennett MK, Payan DG and Scheller RH: Rab37 is a novel mast cell specific GTPase localized to secretory granules. FEBS Lett 470: 61-64, 2000.